Pordy R

References (2)

Title : Evinacumab: Mechanism of action, clinical, and translational science - Dingman_2024_Clin.Transl.Sci_17_e13836
Author(s) : Dingman R , Bihorel S , Gusarova V , Mendell J , Pordy R
Ref : Clin Transl Sci , 17 :e13836 , 2024
Abstract :
PubMedSearch : Dingman_2024_Clin.Transl.Sci_17_e13836
PubMedID: 38845393

Title : Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial - Rosenson_2023_Nat.Med__
Author(s) : Rosenson RS , Gaudet D , Ballantyne CM , Baum SJ , Bergeron J , Kershaw EE , Moriarty PM , Rubba P , Whitcomb DC , Banerjee P , Gewitz A , Gonzaga-Jauregui C , McGinniss J , Ponda MP , Pordy R , Zhao J , Rader DJ
Ref : Nat Med , : , 2023
Abstract :
PubMedSearch : Rosenson_2023_Nat.Med__
PubMedID: 36879129
Gene_locus related to this paper: human-LPL